Interim Report January – June 2024
Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024
Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024
Westlake Vinnolit Customers Appreciate Joint Efforts on Decarbonization
Neogen Announces Fourth-Quarter Earnings Release Date
SOUTH SAN FRANCISCO, CA / ACCESSWIRE / March 7, 2019 / VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing...
Parrish Healthcare has Adopted athenahealth Population Health, a National Population Health Management Technology Solution, to Enhance its Certified Integrated Care...
70% of patients using PainShield experienced complete resolution or significant improvement in symptoms without the use of opioids PainShield had...
COTTONWOOD HEIGHTS, UT / ACCESSWIRE / March 7, 2019 / Dynatronics Corporation (NASDAQ: DYNT), a leading provider of physical therapy,...
BUFFALO, NY / ACCESSWIRE / March 7, 2019 / Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development...
HAMBURG, GERMANY / ACCESSWIRE / March 7, 2019 / Evotec AG (FSE: EVT, OTC PINK: EVTCY, MDAX/TecDAX, ISIN: DE0005664809) announced...
VANCOUVER, BC / ACCESSWIRE / March 7, 2019 / EVITRADE Health Systems Corp. (CSE: EVA, OTCQB: EVAHF) (the "Company") is...
BERKELEY HEIGHTS, NJ / ACCESSWIRE / March 7, 2019 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on...
Association of Bioscience Financial Officers Introduces Speaker Line-Up for 2019 National Conference Set for May 28-31 in Boston BOSTON, MA...
HEIDELBERG, GERMANY / ACCESSWIRE / March 7, 2019 / Apogenix, a biopharmaceutical company developing next generation immuno-oncology therapeutics, announced today...
CALGARY, AB / ACCESSWIRE / March 6, 2019 / Prevent Health Care International Corp. (the "Corporation" or "Prevent") today announced...
Certive Announces Expanded Scope of Work with Major Client and the Closing of its Current Convertible Debt Offering SCOTTSDALE, AZ...
SAN DIEGO, CA / ACCESSWIRE / March 6, 2019 / Targazyme, a clinical-stage biopharmaceutical company developing novel enzyme products to...
OTTAWA, ON / ACCESSWIRE / March 6, 2019 / Today's announcement on national pharmacare is an important step forward in...
PARIS, FRANCE / ACCESSWIRE / March 6, 2019 / Pharnext SA (FR0011191287 - ALPHA), a biopharmaceutical company pioneering a new...
LOS ANGELES, CA / ACCESSWIRE / March 6, 2019 / Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing...
Aytu Assumes Milestone & Royalty-Based Licensing Agreement with SUDA Pharmaceuticals to Sublicense ZolpiMist Outside of the United States and Canada...
HACKENSACK, NJ / ACCESSWIRE / March 6, 2019 / Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of...
France is a Significant Market for Intravitreal Steroid Use ATLANTA, GA / ACCESSWIRE / March 6, 2019 / Alimera Sciences,...
ROCKVILLE MD / ACCESSWIRE / March 5, 2019 / Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a...
